Dyne Therapeutics CEO Joshua Brumm's 2021 pay falls 66% to $4.1M
Dyne Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Dyne Therapeutics reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, three executives at Dyne Therapeutics received on average a compensation package of $2.9M, a 57% decrease compared to previous year.
Average pay of disclosed executives at Dyne Therapeutics
Joshua Brumm, Chief Executive Officer, received $4.1M in total, which decreased by 66% compared to 2020. 38% of Brumm's compensation, or $1.6M, was in stock awards. Brumm also received $452K in non-equity incentive plan, $1.5M in option awards, $562K in salary, as well as $13K in other compensation.
Oxana Beskrovnaya, Chief Scientific Officer, received a compensation package of $2.9M. 63% of the compensation package, or $1.8M, was in stock awards.
Susanna High, Chief Operating Officer, earned $1.7M in 2021, a 55% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2022.